Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders.

Antioxidants (Basel) · 2021 · PMC7912005 · PMID 33499329

Europe PMC DOI

hedged sentence

0.1360

closest p · 2.7× alpha

0.1360

boldest claim

The sentences

did not reach statistical significancep = 0.136not close (p > 0.1)

The arylesterase activity was significantly lower in the ADHD sample compared with the healthy controls (HSD Tukey: p < 0.01), to SLI cases ( p < 1.2 × 10 −5 ) and to both ASD parent samples ( p < 0.05), whereas differences between ADHD and ASD did not reach statistical significance ( p = 0.136).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.